[1]
|
F. Wolfe, H. A. Smyte, M. B. Yunus, R. M. Bennet, C. Bombardier, D. L. Goldenberg, P. Tugwell, S. M. Campell, M. Abeles, P. Clark, et al., “The American Collage of Rheumatology 1990 Criteria for Classification of Fi- bromyalgia: Report of the Multicentre Criteria Committee,” Arthritis & Rheumatism, Vol. 33, No. 2, 1990, pp. 160-172. doi:10.1002/art.1780330203
|
[2]
|
S. ?zkurt, A. D?nmez, M. Z. Karagülle, E. Uzuno?lu, M. Turan and N. Erdo?an, “Balneotherapy in Fibromyalgia: A Single Blind Randomized Controlled Clinical Study,” Rheumatology International, Vol. 32, No. 7, 2012, pp. 1949-1954. doi:10.1007/s00296-011-1888-9
|
[3]
|
F. Wolfe, K. Ross, J. Anderson, I. J. Russel and L. Hebert, “The Prevalence and Charecteristics of Fibromyalgia in the General Population,” Arthritis & Rheumatism, Vol. 38, No. 1, 1995, pp. 19-28. doi:10.1002/art.1780380104
|
[4]
|
M. Topba?, H. ?ak?rbay and H. Güle?, “The Prevalence of Fibromyalgia in Women Aged 20-64 in Turkey,” Scandinavian Journal of Rheumatology, Vol. 34, No. 2, 2005, pp. 140-144.
|
[5]
|
L. Neumann and D. Buskila, “Quality of Life and Physical Functioning of Relatives of Fibromyalgia Patients,” Seminars in Arthritis and Rheumatism, Vol. 26, No. 6, 1997, pp. 834-839. doi:10.1016/S0049-0172(97)80027-3
|
[6]
|
T. Bardin, “Musculoskeletal Manifestations of Chronic Renal Failure. Systemic Disorders with Rheumatic Manifestations,” Current Opinion in Rheumatology, Vol. 15, No. 1, 2003, pp.48-54.
doi:10.1097/00002281-200301000-00009
|
[7]
|
C. I. Couto, J. Natour and A. B. Carvalho, “Fibromyalgia: Its Prevalence and ?mpact on the Quality of Life on a Hemodialyzed Population,” Hemodialysis International, Vol. 12, No. 1, 2008, pp. 66-72.
doi:10.1111/j.1542-4758.2008.00243.x
|
[8]
|
T. E. Yuceturk, A. E. Yucel, H. Yuceturk, H. Kart-Koseoglu, R. Unuvar, F. N. Ozdemir and Z. Akcali, “Fibromyalgia: ?ts Prevalence in Hemodialysis Patients and ?ts Relationships with Clinical and Laboratory Parameters,” Nephrology Dialysis Transplantation, Vol. 20, No. 11, 2005, pp. 2485-2488. doi:10.1093/ndt/gfi028
|
[9]
|
W. G. Thompson, G. F. Longstreth, D. A. Drossman, K. W. Heaton, E. J. Irvine and S. A. Muller-Lissner, “Functional Bowel Disorders and Functional Abdominal Pain,” Gut, Vol. 45, No. 2, 1999, pp. 1143-1147.
doi:10.1136/gut.45.2008.ii43
|
[10]
|
C. S. Burckhardt, S. R. Clark and R. M. Bennett, “The Fibromyalgia ?mpact Questionnaire: Development and Validation,” The Journal of Rheumatology, Vol. 8, No. 5, 1991, pp. 728-733.
|
[11]
|
S. Sarmer, S. Ergin and G. Yavuzer, “The Validity and Realibility of the Turkish Version of the Fibromyalgia ?mpact Questionnaire,” Rheumatology International, Vol. 20, No. 1, 2000, pp. 9-12. doi:10.1007/s002960000077
|
[12]
|
T. D. Wade, “Measures of Handicap and Quality of Life,” In: T. Wade, Ed., Measurement in Neurological Rehabilitation, Oxford University Press, London, 1992, pp. 231- 259.
|
[13]
|
A. A. Kucukdeveci, S. P. Mckenna, S. Kutlay, Y. Gursel, D. Whalley and T. Arasil, “The Development and Psychometric Assessment of the Turkish Version of the Nottingham Health Profile,” International Journal of Rehabilitation Research, Vol. 23, No. 1, 2000, pp. .31-38.
|
[14]
|
A. E. Yucel, H. Kart-Koseoglu, I. Isklar, E. Kuruinci, F. N. Ozdemir and H. Arslan, “Bone Mineral Density in Patients on Maintenance Hemodialysis and Effect of Chronic Hepatitis C-Virus Enfection,” Renal Failure, Vol. 26, No. 2, 2004, pp. 159-164. doi:10.1081/JDI-120038501
|
[15]
|
M. P. Merkus, K. J. Jager, F. W. Dekker, R. J. de Haan, E. W. Boeschoten and R. T. Krediet, “Predictors of Poor Outcome in Chronic Dialysis Patients: The Netherlands Cooperative Study on the Adequacy of Dialysis. The NECOSAD Study Group,” American Journal of Kidney Diseases, Vol. 35. No. 1, 2000, pp. 69-79.
doi:10.1016/S0272-6386(00)70304-0
|
[16]
|
S. Roizenbatt, H. Moldofsky, A. A. Benedito-Silva and S. Tufik, “Alpha Sleep Characteristic in Fibromyalgia,” Arthritis and Rheumatism, Vol. 44, No. 1, 2001, pp. 222-230.
|
[17]
|
G. Tridafilopoulus, R. W. Simms and D. L. Goldenderb, “Bowel Dysfunction in Fibromyalgia Syndrome,” Digestive Diseases and Sciences, Vol. 36, No. 1, 1991, pp. 59-64. doi:10.1007/BF01300088
|
[18]
|
F. Wolfe, M. A. Cathey, S. M. Kleinheksel, S. P. Amos, R. G. Hoffman, D. Y. Young and D. J. Hawley, “Psychological Status in Primary Fibrositis and Fibrositis Associated with Rhematoid Arthritis,” The Journal of Rheumatology, Vol. 11, No. 4, 1984, pp. 500-506.
|
[19]
|
D. J. Sherrard, G. Herez, Y. Pei, N. A. Maloney, C. Greenwood, A. Manuel, C. Saiphoo, S. S. Fenton and G. V. Segre, “The Spectrum of Bone Disease in End-Stage Renal Failure—An Evolving Disorder,” Kidney International, Vol. 43, No. 2, 1993, pp. 436-442.
doi:10.1038/ki.1993.64
|
[20]
|
D. Wendling and M. Guidet, “Articular and Periarticular Manifestations of Chronic Hemodialysis in the Adult,” Revue du Rhumatisme et des Maladies Ostéo-Articulaires, Vol. 53, No. 12, 1986, pp. 715-721.
|
[21]
|
K. C. Siamopoulos, M. Dardamanis, D. Kyriaki, M. Pappas, G. Siferopoulos and V. Alevisou, “Pituitary Adrenal Responsivenes to CRF in Chronic Uremic Patients,” Peritoneal Dialysis ?nternational, Vol. 10, No. 2, 1990, pp. 153-156.
|
[22]
|
E. M. Kaptein, “Thyroid Hormone Metabolism and Thyroid Diseases in Chronic Renal Failure,” Endocrine Re- views, Vol. 17, No. 1, 1996, pp. 45-63.
doi:10.1210/edrv-17-1-45
|
[23]
|
E. G. Lowrie, J. M. Lazarus, A.J. Mocelin, G. L. Bailey, C. L. Hampers, R. E. Wilson and J. P. Merrill, “Survival of Patients Undergoing Chronic Hemodialysis and Renal Transplantation,” The New England Journal of Medicine, Vol. 288. No. 17, 1973, pp. 863-867.
doi:10.1056/NEJM197304262881701
|
[24]
|
R. W. Evans, D. L. Manninen, L. P. Garrison, L. G. Hart, C. R. Blagg, R. A. Gutman, A. R. Hull and E. G. Lowrie, “The Quality of Life Patients with End-Stage Renal Disease,” The New England Journal of Medicine, Vol. 312, No. 9, 1985, pp. 553-559.
doi:10.1056/NEJM198502283120905
|